Paredrine

Active Ingredient(s): Hydroxyamphetamine
FDA Approved: * July 16, 1969
Pharm Company: * AKORN
Category: Vision / Eye Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Paredrine Overview

4-Hydroxyamphetamine (4HA), also known as hydroxyamfetamine, hydroxyamphetamine, oxamphetamine, norpholedrine, para-hydroxyamphetamine, and α-methyltyramine, is a drug that stimulates the sympathetic nervous system. It is used medically in eye drops to dilate the pupil (a process called mydriasis), so that the back of the eye can be examined. It is also a major metabolite of amphetamine and certain substituted amphetamines. Contents 1 Medical use 2 Pharmacology 3 Commercialization...

Read more Paredrine Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Hydroxyamfetamine

Recent Paredrine Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Hydroxyamphetamine
  • Solution/drops: 1%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Hydroxyamphetamine or a similar ingredient: (3 results)





Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. Site content is Copyright © 2005-2018 MedsChat.com and is protected under U.S. and International Copyright laws. All Rights Reserved. This page was last updated on 17 January 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® and The People's Medicine Community® are registered trademarks of Limelight Innovations L.L.C.